Analysis and Commentary STEVEN GROSSMAN 12/10/18 Analysis and Commentary STEVEN GROSSMAN 12/10/18 Critical Issues for the CVM Moving Forward Read More Advocacy at a Glance STEVEN GROSSMAN 12/10/18 Advocacy at a Glance STEVEN GROSSMAN 12/10/18 Two-Week CR Extension: Can It End the Impasse? Read More Advocacy at a Glance STEVEN GROSSMAN 11/30/18 Advocacy at a Glance STEVEN GROSSMAN 11/30/18 A Full Year Continuing Resolution: The Biggest Threat to FDA’s FY19 Funding Read More Advocacy at a Glance STEVEN GROSSMAN 11/20/18 Advocacy at a Glance STEVEN GROSSMAN 11/20/18 Special Thanksgiving Message Read More Advocacy at a Glance STEVEN GROSSMAN 11/9/18 Advocacy at a Glance STEVEN GROSSMAN 11/9/18 Will Congress Complete Appropriations in the Post-Recess Session or Further Extend the CR? Read More Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Alliance’s Hill Day on April 25. Please Join Us Read More
Analysis and Commentary STEVEN GROSSMAN 12/10/18 Analysis and Commentary STEVEN GROSSMAN 12/10/18 Critical Issues for the CVM Moving Forward Read More
Advocacy at a Glance STEVEN GROSSMAN 12/10/18 Advocacy at a Glance STEVEN GROSSMAN 12/10/18 Two-Week CR Extension: Can It End the Impasse? Read More
Advocacy at a Glance STEVEN GROSSMAN 11/30/18 Advocacy at a Glance STEVEN GROSSMAN 11/30/18 A Full Year Continuing Resolution: The Biggest Threat to FDA’s FY19 Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 11/20/18 Advocacy at a Glance STEVEN GROSSMAN 11/20/18 Special Thanksgiving Message Read More
Advocacy at a Glance STEVEN GROSSMAN 11/9/18 Advocacy at a Glance STEVEN GROSSMAN 11/9/18 Will Congress Complete Appropriations in the Post-Recess Session or Further Extend the CR? Read More
Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Advocacy at a Glance STEVEN GROSSMAN 4/21/18 Alliance’s Hill Day on April 25. Please Join Us Read More
